mRNA |
A-443654 |
GDSC1000 |
pan-cancer |
AAC |
0.0074 |
0.9 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
0.0044 |
0.9 |
mRNA |
KU-0063794 |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
mRNA |
BRD-K92856060 |
CTRPv2 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
OSI-027 |
CTRPv2 |
pan-cancer |
AAC |
0.0039 |
0.9 |